First Citizens Bank & Trust Co. lessened its stake in PerkinElmer, Inc. (NYSE:PKI) by 14.4% in the 4th quarter, according to its most recent filing with the SEC. The firm owned 23,598 shares of the medical research company’s stock after selling 3,970 shares during the quarter. First Citizens Bank & Trust Co.’s holdings in PerkinElmer were worth $1,726,000 as of its most recent filing with the SEC.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Ontario Teachers Pension Plan Board boosted its stake in shares of PerkinElmer by 36.3% in the 2nd quarter. Ontario Teachers Pension Plan Board now owns 95,415 shares of the medical research company’s stock valued at $6,502,000 after buying an additional 25,404 shares during the period. Neuberger Berman Group LLC boosted its stake in shares of PerkinElmer by 59.8% in the 2nd quarter. Neuberger Berman Group LLC now owns 52,030 shares of the medical research company’s stock valued at $3,545,000 after buying an additional 19,464 shares during the period. State of Wisconsin Investment Board purchased a new position in shares of PerkinElmer in the 3rd quarter valued at about $1,673,000. Bessemer Group Inc. boosted its stake in shares of PerkinElmer by 22.2% in the 3rd quarter. Bessemer Group Inc. now owns 27,149 shares of the medical research company’s stock valued at $1,873,000 after buying an additional 4,936 shares during the period. Finally, Sivik Global Healthcare LLC boosted its stake in shares of PerkinElmer by 12.5% in the 3rd quarter. Sivik Global Healthcare LLC now owns 90,000 shares of the medical research company’s stock valued at $6,207,000 after buying an additional 10,000 shares during the period. Institutional investors and hedge funds own 91.37% of the company’s stock.

Several brokerages have recently issued reports on PKI. Zacks Investment Research upgraded PerkinElmer from a “hold” rating to a “buy” rating and set a $86.00 price objective for the company in a research note on Monday. Citigroup reiterated a “buy” rating and issued a $80.00 price objective (up previously from $74.00) on shares of PerkinElmer in a research note on Tuesday, September 26th. Goldman Sachs Group reiterated a “neutral” rating and issued a $67.00 price objective on shares of PerkinElmer in a research note on Tuesday, September 26th. Evercore ISI started coverage on PerkinElmer in a research note on Wednesday, January 3rd. They set an “in-line” rating and a $77.00 target price for the company. Finally, ValuEngine cut PerkinElmer from a “buy” rating to a “hold” rating in a research note on Friday, December 1st. One research analyst has rated the stock with a sell rating, eleven have issued a hold rating and six have assigned a buy rating to the company. The stock currently has a consensus rating of “Hold” and a consensus target price of $72.29.

In related news, insider Andrew Okun sold 12,680 shares of the business’s stock in a transaction that occurred on Friday, December 15th. The stock was sold at an average price of $72.00, for a total transaction of $912,960.00. Following the completion of the sale, the insider now owns 25,121 shares in the company, valued at $1,808,712. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, Director Peter Barrett sold 7,071 shares of PerkinElmer stock in a transaction that occurred on Monday, November 13th. The stock was sold at an average price of $71.07, for a total value of $502,535.97. Following the transaction, the director now directly owns 26,271 shares in the company, valued at approximately $1,867,079.97. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 86,336 shares of company stock valued at $6,114,917. 2.20% of the stock is owned by company insiders.

Shares of PerkinElmer, Inc. (PKI) opened at $77.14 on Thursday. The firm has a market capitalization of $8,500.00, a P/E ratio of 34.90, a P/E/G ratio of 1.85 and a beta of 0.77. PerkinElmer, Inc. has a 52 week low of $50.59 and a 52 week high of $78.19. The company has a debt-to-equity ratio of 0.44, a quick ratio of 2.09 and a current ratio of 2.59.

The firm also recently announced a quarterly dividend, which will be paid on Friday, February 9th. Investors of record on Friday, January 19th will be paid a dividend of $0.07 per share. This represents a $0.28 annualized dividend and a yield of 0.36%. The ex-dividend date is Thursday, January 18th. PerkinElmer’s payout ratio is 12.67%.

COPYRIGHT VIOLATION WARNING: “First Citizens Bank & Trust Co. Sells 3,970 Shares of PerkinElmer, Inc. (PKI)” was posted by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are accessing this article on another site, it was stolen and reposted in violation of US and international copyright and trademark legislation. The legal version of this article can be read at https://www.thecerbatgem.com/2018/01/11/first-citizens-bank-trust-co-sells-3970-shares-of-perkinelmer-inc-pki.html.

PerkinElmer Company Profile

PerkinElmer, Inc is a provider of products, services and solutions to the diagnostics, research, environmental, industrial and laboratory services markets. The Company operates through two segments: Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions segment serves the environmental, food, industrial, life sciences research and laboratory services markets.

Want to see what other hedge funds are holding PKI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for PerkinElmer, Inc. (NYSE:PKI).

Institutional Ownership by Quarter for PerkinElmer (NYSE:PKI)

Receive News & Ratings for PerkinElmer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PerkinElmer and related companies with MarketBeat.com's FREE daily email newsletter.